سعر اورفامول 20 اقراص 2025

Combination tablet of orphenadrine citrate 35 mg (centrally acting muscle relaxant) and paracetamol 450 mg (analgesic) by Rameda; 20 tablets.

• Tension headache and occipital headaches associated with spasm of skeletal muscles of the head and neckPopulation: AdultsiNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Acute and traumatic conditions of the limbs and trunk: sprains, strains, whiplash injuries, acute torticollis, prolapsed intervertebral discPopulation: AdultsiNova Pharmaceuticals / medsinfo (TGA-approved PI)

• Mainly anticholinergic effects of orphenadrine: dry mouth, tachycardia, palpitations, urinary hesitancy or retention, blurred vision, pupil dilation, raised ocular pressure, weakness, nausea, headache, dizziness, constipation and drowsiness.International label, equivalent formulation · iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Paracetamol: rare hypersensitivity reactions, blood dyscrasias (thrombocytopenia, neutropenia, agranulocytosis) and hepatitis.International label, equivalent formulation · iNova Pharmaceuticals / medsinfo (TGA-approved PI)

• Glaucoma; prostatic hypertrophy or bladder-neck obstruction; myasthenia gravis; oesophageal spasm and pyloric or duodenal obstruction; hypersensitivity to paracetamol, orphenadrine citrate or any excipient.International label, equivalent formulation · iNova Pharmaceuticals / medsinfo (TGA-approved PI)

• Use orphenadrine with caution in tachycardia, cardiac decompensation, coronary insufficiency, arrhythmias, Gilbert syndrome and G6PD deficiency.International label, equivalent formulation · iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Paracetamol may cause hepatotoxicity even at therapeutic doses; avoid other paracetamol- or orphenadrine-containing medicines.International label, equivalent formulation · iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Serious skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with paracetamol; stop treatment if they occur.International label, equivalent formulation · iNova Pharmaceuticals / medsinfo (TGA-approved PI)

• Phenothiazines and other antimuscarinic drugsInteractions reported with orphenadrine.iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Alcohol and other CNS depressantsConcomitant use should be avoided.iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Warfarin and other vitamin K antagonistsParacetamol may increase bleeding risk; monitor coagulation.iNova Pharmaceuticals / medsinfo (TGA-approved PI)

• Australian pregnancy category B2; the product is not recommended during pregnancy.International label, equivalent formulation · iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Should not be taken during lactation because orphenadrine and paracetamol are excreted into breast milk.International label, equivalent formulation · iNova Pharmaceuticals / medsinfo (TGA-approved PI)

English text not available for this section.